CHMP gives positive opinion extended indication for Rebif

A board to discuss the Multiple Sclerosis modifying drug Rebif

CHMP gives positive opinion extended indication for Rebif

Postby MSUK » Mon Nov 21, 2011 3:14 am

CHMP gives positive opinion for extended indication for Rebif® for patients with early signs Of MS

Image

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), for its variation application to extend the indication of Rebif (interferon beta-1a), its leading treatment for relapsing forms of multiple sclerosis (MS).

The positive CHMP opinion is for the use of Rebif 44 micrograms three times weekly in patients who have experienced a single demyelinating event, an early sign of the disease, and who are at high risk of converting to MS... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1901
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2092
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Rebif

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users